Pregled bibliografske jedinice broj: 1118698
No Adverse Effects After Radioiodine Treatment at 3 Weeks of Pregnancy
No Adverse Effects After Radioiodine Treatment at 3 Weeks of Pregnancy // Clinical Nuclear Medicine, 41 (2016), 12; 964-965 doi:10.1097/rlu.0000000000001376 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1118698 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
No Adverse Effects After Radioiodine Treatment at 3
Weeks of Pregnancy
Autori
Radacic-Aumiler, Matea ; Kraljickovic, Iva ; Edeljic-Turk, Viktorija ; Makar-Ausperger, Ksenija ; Likic, Robert ; Simic, Iveta
Izvornik
Clinical Nuclear Medicine (0363-9762) 41
(2016), 12;
964-965
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
radioactive iodine, hyperthyroidism, pregnancy
Sažetak
Radioactive iodine is used for the treatment of hyperthyroidism. Because it accumulates in the fetal thyroid, its administration during pregnancy may cause severe and potentially irreversible hypothyroidism in neonates, with consequent mental retardation, and it is contraindicated during the whole pregnancy. We present a case of a pregnant woman inadvertently treated with 1 mCi (37 MBq) of I in the earliest period of pregnancy and subsequently gave birth to a male infant without signs or symptoms of hypothyroidism or any other damage. This case illustrates that when radioactive iodine administration happens around the third week of gestation pregnancy outcome can be normal.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE